Evidence map›Paper›PMID 34738086›Full record

ArticleCerebral cortex communications2021

Dopaminergic Basis of Spatial Deficits in Early Parkinson's Disease.

B Hanna-Pladdy, R Pahwa, K E Lyons

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cerebral cortex communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

B Hanna-PladdyCenter for Advanced Imaging Research (CAIR), Department of Diagnostic Radiology & Nuclear Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA.ORCID https://orcid.org/0000-0001-7806-3843
R PahwaParkinson's Disease and Movement Disorder Center, Department of Neurology, University of Kansas Medical Center, Kansas City, KS 66160, USA.
K E LyonsParkinson's Disease and Movement Disorder Center, Department of Neurology, University of Kansas Medical Center, Kansas City, KS 66160, USA.
University of Kansas Medical Center · USUniversity of Maryland, Baltimore · US

Funding

Functional MRI Biomarkers Predicting Cognitive Progression in PDR01NS098249 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE · PI HANNA-PLADDY, BRENDA · 2017 to 2021
$2.4M
Dopaminergic Modulation Of Cognitive Aspects Of Skill Acquisition In PDR21NS059649 · NINDS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI HANNA-PLADDY, BRENDA · 2009 to 2010
$413k
NINDS NIH HHS R01 NS098249NINDS NIH HHS R21 NS059649
6 · The paper itself

Abstract

Dopaminergic mechanisms regulating cognitive and motor control were evaluated comparing visuoperceptual and perceptuomotor functions in Parkinson's disease (PD). The performance of PD patients (n = 40) was contrasted with healthy controls (n = 42) across two separate visits (

Indexed as

dopaminergic modulationmovement velocityParkinson Diseasespatial accuracyvisuoperceptual

Identifiers

PMID34738086
PMCPMC8436572
OpenAlexW3175877802

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.